Alyssa Peterkin MD is board certified in internal medicine and addiction medicine. She received her medical degree from New York Medical College and completed residency in Internal Medicine at Mount Auburn Hospital in Cambridge, MA. As a graduate of the Grayken Addiction Medicine Fellowship, her interests include addiction education and expanding access to substance use disorder treatment. She works as a hospitalist, regularly attends on the inpatient addiction consult service and works in Faster Paths which is Boston Medical Center’s low barrier substance use disorder clinic. She currently serves as Program Director for the Grayken Addiction Medicine Fellowship, Co-Director of the Addiction and Health Track in the LEADS course at the Boston University Chobanian & Avedisian School of Medicine and works on a NIDA-funded clinical trial as a medical clinician.
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine
- New York Medical College, MD
- Boston University, BA
- MS 137
- MS 310
- Published on 2/7/2023
Rozansky H, Awtry E, Weinstein ZM, Peterkin AF. Grayken lessons: the role of an interdisciplinary endocarditis working group in evaluating and optimizing care for a woman with opioid use disorder requiring a second tricuspid valve replacement. Addict Sci Clin Pract. 2023 Feb 07; 18(1):9. PMID: 36750906.
- Published on 1/25/2023
Peterkin AF, Jawa R, Menezes K, You J, Cabral H, Ruiz-Mercado G, Park TW, Kehoe J, Taylor JL, Weinstein ZM. Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use Disorder. Subst Use Misuse. 2023; 58(4):585-589. PMID: 36695079.
- Published on 1/9/2023
Laks J, Walley AY, Bagley SM, Barber CM, Gaeta JM, Neville LA, Peterkin AF, Rosenthal E, Saia KA, Weinstein ZM, Harris MTH. Developing a Women's Health track within addiction medicine fellowship: reflections and inspirations. Addict Sci Clin Pract. 2023 Jan 09; 18(1):3. PMID: 36617557.
- Published on 11/11/2022
Sulakvelidze N, Ronan C, Peterkin AF, Weinstein ZM. Efficacy of Low-Dose Versus Traditional Buprenorphine Induction in the Hospital: A Quantitative and Qualitative Study. Am J Ther. 2023 Jan-Feb 01; 30(1):e1-e9. PMID: 36608069.
- Published on 7/26/2022
Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022 Sep; 17(9):679-692. PMID: 35880821.
- Published on 3/1/2022
Peterkin A, Davis CS, Weinstein Z. Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism. J Addict Med. 2022 Mar-Apr 01; 16(2):127-129. PMID: 33758114.
- Published on 2/4/2022
Peterkin AF, Abraham R, Harris MTH. A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic. J Addict Med. 2022 Sep-Oct 01; 16(5):602-605. PMID: 35120058.
- Published on 1/1/2022
Peterkin A, Laks J, Weinstein ZM. Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder. Med Clin North Am. 2022 Jan; 106(1):61-80. PMID: 34823735.
- Published on 4/28/2021
Harris MTH, Peterkin A, Bach P, Englander H, Lapidus E, Rolley T, Weimer MB, Weinstein ZM. Correction to: Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract. 2021 Apr 28; 16(1):25. PMID: 33910637.
- Published on 2/24/2021
Harris MTH, Peterkin A, Bach P, Englander H, Lapidus E, Rolley T, Weimer MB, Weinstein ZM. Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract. 2021 02 24; 16(1):13. PMID: 33627183.